Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAFV600E mutations: Results from the TAPUR Study
Publication
, Conference
Klute, K; Garrett-Mayer, E; Halabi, S; Mangat, PK; Nazemzadeh, R; Yost, KJ; Butler, NL; Perla, V; Schilsky, RL
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Klute, K., Garrett-Mayer, E., Halabi, S., Mangat, P. K., Nazemzadeh, R., Yost, K. J., … Schilsky, R. L. (2020). Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Klute, Kelsey, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Reza Nazemzadeh, Kathleen J. Yost, Nicole L. Butler, Venu Perla, and Richard L. Schilsky. “Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Klute K, Garrett-Mayer E, Halabi S, Mangat PK, Nazemzadeh R, Yost KJ, et al. Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Klute, Kelsey, et al. “Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 4, 2020.
Klute K, Garrett-Mayer E, Halabi S, Mangat PK, Nazemzadeh R, Yost KJ, Butler NL, Perla V, Schilsky RL. Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences